Search
01/09/2025
Adapting Barlow's Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Overweight Adults: A Nonrandomized Controlled Feasibility Study
Gawron, LP, Clifford, KR, Guillén, AR, Carceller-Sindreu, M, Farrés, CC, Bonnin, CD, Portella, MJ. Adapting Barlow's Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Overweight Adults: A Nonrandomized Controlled Feasibility Study. INTERNATIONAL JOURNAL OF EATING DISORDERS. 2025; 58(9)DOI:10.1002/eat.24474. PMID:40418102. IF:4.300(Q1/1D).
01/09/2025
Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments
Cendrós, M, Catalán, R, Torra, M, Penadés, R, González-Rodríguez, A, Brunet, M, Perez-Blanco, J, Cullell, N, Serra-Llovich, A, Hernandez, MH, Arranz, MJ. Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments. PHARMACOPSYCHIATRY. 2025; 58(05)DOI:10.1055/a-2603-0871. PMID:40527340. IF:2.200(Q3/6D).
01/09/2025
Occipital structure is linked to vagal tone in borderline personality but not in major depressive disorder
Camacho-Tellez, V, Castro, MN, De Pino, G, Duarte-Abritta, B, Wainsztein, AE, Herlyn, DL, Goldberg, X, Costanzo, EY, Cordoner, N, Menchón, JM, Soriano-Mas, C, Guinjoan, SM, Villarreal, MF. Occipital structure is linked to vagal tone in borderline personality but not in major depressive disorder. PSYCHIATRY RESEARCH-NEUROIMAGING. 2025; 352DOI:10.1016/j.pscychresns.2025.112044. PMID:40818358. IF:2.100(Q1/1D).
01/09/2025
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease
Jessen, F, Arbizu, J, Boada, M, Balasa, M, Bennys, K, Boban, M, Bürger, K, Chincarini, A, Cagnin, A, De Deyn, PP, Düzel, E, Engelborghs, S, Ewers, M, Exalto, LG, van der Flier, WM, Fortea, J, Frederiksen, KS, Frisoni, GB, Frölich, L, Garza-Martinez, AJ, Grimmer, T, Hanseeuw, B, Hort, J, Ivanoiu, A, Kehoe, PG, Kennelly, SP, Kern, S, Klöppel, S, Krajcovicová, L, Kramberger, MG, McGuinness, B, Mecocci, P, Oberstein, TJ, Ousset, PJ, Paquet, C, Perneczky, R, Piazza, F, Plantone, D, Rainero, I, Sacco, G, Salm, E, Santana, I, Scarmeas, N, Schneider, A, Schott, JM, Solje, E, Stefanova, E, Stögmann, E, Strauss, M, Sutovsky, S, Waldemar, G, Winblad, B. Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease. JPAD-Journal of Prevention of Alzheimers Disease. 2025; 12(8)DOI:10.1016/j.tjpad.2025.100259. PMID:40640062. IF:7.800(Q1/1D).